Total: 5 |
|
PMID (PMCID) | ||
---|---|---|
26056798 |
MIXED_SAMPLE | Child |
Predicting, Monitoring, and Managing Hypercalcemia Secondary to 13-Cis-Retinoic Acid Therapy in Children With High-risk Neuroblastoma. | ||
Chen SC, Murphy D, Sastry J, Shaikh MG. J Pediatr Hematol Oncol. 2015;37(6):477-81. |
||
Predicting, Monitoring, and Managing Hypercalcemia Secondary to 13-Cis-Retinoic Acid Therapy in Children With High-risk Neuroblastoma. | ||
12013365 |
FEMALE | Child |
Hypercalcemia induced by 13-cis-retinoic acid in a patient with neuroblastoma. | ||
Belden TL, Ragucci DP. Pharmacotherapy. 2002;22(5):645-8. |
||
Hypercalcemia induced by 13-cis-retinoic acid in a patient with neuroblastoma. | ||
12013365 |
FEMALE | Child |
Hypercalcemia induced by 13-cis-retinoic acid in a patient with neuroblastoma. | ||
Belden TL, Ragucci DP. Pharmacotherapy. 2002;22(5):645-8. |
||
A 12-year-old girl without renal dysfunction, diagnosed with neuroblastoma, developed severe hypercalcemia requiring several hospitalizations while receiving 13-cis-retinoic acid 160 mg/m2/day. | ||
157070 |
MALE | Child |
Hypercalcemia associated with neuroblastoma. | ||
Al-Rashid RA, Cress C. Am J Dis Child. 1979;133(8):838-41. |
||
We studied two children with neuroblastoma in whom hypercalcemia developed as the initial manifestation in one and during the course of therapy in the other. | ||
157070 |
MALE | Child |
Hypercalcemia associated with neuroblastoma. | ||
Al-Rashid RA, Cress C. Am J Dis Child. 1979;133(8):838-41. |
||
Hypercalcemia associated with neuroblastoma. |